IRAK-2 Inhibitors

IRAK-2 inhibitors encompass a range of compounds that indirectly target IRAK-2 by modulating associated signaling pathways, particularly those involving NF-κB, a key factor in immune and inflammatory responses. These inhibitors primarily work by altering the activity of NF-κB, which is closely linked to the function of IRAK-2 in immune signaling cascades.

Compounds like parthenolide, wedelolactone, Bay 11-7082, and celastrol are known to inhibit the NF-κB pathway. By doing so, they indirectly affect IRAK-2, which is involved in the activation of NF-κB. The inhibition of this pathway can lead to a reduction in IRAK-2 mediated signaling, thus modulating immune responses. Additionally, antioxidants such as resveratrol and quercetin also modulate NF-κB activity, thereby potentially impacting IRAK-2 functions. Curcumin, with its broad-spectrum anti-inflammatory properties, modulates NF-κB and other signaling pathways, which can indirectly influence IRAK-2 activity. Furthermore, compounds like sulforaphane and epigallocatechin gallate (EGCG) induce Nrf2 and inhibit NF-κB, respectively, thereby affecting signaling pathways related to IRAK-2. Andrographolide and piperlongumine, with their diverse effects on cellular signaling, also potentially modulate IRAK-2 activity.